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2Categorization of graphene-based materials
One important concern in graphene research is that the term “graphene” is used in a 
generic manner to describe many different graphene-based materials (GBMs). In an 
attempt to remedy this situation, the Graphene Flagship proposed a classification 
scheme for GBMs that takes into account three key parameters: the number of 
graphene layers, the average lateral size, and the carbon-to-oxygen (C:O) atomic 
ratio.1 The use of such a classification framework may facilitate the comparison 
between studies performed in different laboratories and may also enable the 
assignment of specific physicochemical properties with the safety profile of GBMs.
In the following section, we have prepared 3D plots to illustrate the range of GBMs 
that have been subjected to toxicological studies, focusing on a few selected areas 
for which a reasonable number of studies have been published. The first figure 
(Figure S1) reports the GBMs that have been investigated in the Graphene Flagship 
in recent years (see Table S1 for details). Most of the studies were conducted on GO 
of differing lateral dimensions. The second figure focuses on publications dealing 
with macrophage interactions. The different materials fall into three distinct volumes. 
Most of them correspond to GO within a narrow range in terms of thickness (number 
of layers) and carbon/oxygen ratio, while the lateral dimensions cover a broader 
spectrum (Figure S2). Generally, these GOs all triggering the activation of primary or 
immortalized macrophages, while the effect on cell viability remains limited, 
becoming significant only at high concentrations (i.e., 100 µg/mL). The second 
volume is related to a cluster of materials corresponding to reduced GO and 
graphene of different size and thickness with a low content of oxygen. The decrease 
of the number of oxygenated functions on GO surface has a clear impact on the toxic 
effect of graphene in vitro and in vivo. The third volume contains four materials with 
the highest number of layers and the highest lateral size, which correspond to 
partially exfoliated graphite sheets in the microscale range (erroneously referred to 
as "nanographites") and to GO with a very high lateral size. Only a low dose-
dependent release of proinflammatory cytokines and production of ROS was 
measured. Cell viability was also not affected, likely because such big sheets are not 
internalized by the cells and the interactions with the cell membrane does not trigger 
the same activation of the receptors as found for GO. We also analyzed the 
publications available on biodegradation of GBMs. The analysis reported in Figure 
S3 offers a comparative glance of the current landscape around the biodegradation 
3potential of GBMs. The analysis revealed the importance of the surface chemistry of 
each material. The surface chemistry determines the interaction of GBMs with 
biological systems. As a consequence, any modification of the surfaces will likely 
impact their toxic effects and biopersistence. On the other hand, the aqueous 
colloidal stability of each nanomaterial and the degradation conditions, also play an 
important role in their (bio)degradability. According to Figure S3, one might conclude 
that biodegradation is more favorable for the GBMs with a low number of layers and 
a high number of defects. However, the degradation conditions, such as the type of 
artificial oxidative method (i.e., photo-Fenton reaction) or the type of enzyme or 
bacteria, also play a crucial role. In addition, the presence of some gaps regarding 
the biodegradation of GBMs, mainly due to the lack of examples with different 
physicochemical characteristics, evidences the urgent need for more research in this 
area. Figure S4, in turn, shows the studies reported on pulmonary effects of GBMs. 
The materials range from multi-layered graphene nanoplatelets (GNPs) to atomically 
thin GO sheets. At present, the majority of studies are concerned with GO and our 
analysis shows that small lateral dimensions are more frequently associated with 
toxicological effects. Finally, we have summarized available in vitro studies on 
gastrointestinal effects in Figure S5. The results of this analysis show that GBMs are 
apparently inert towards intestinal cells, though the relatively small number of studies 
precludes any wide-ranging conclusions. Overall, as more and more publications are 
reported, it is important to assign the toxicity profiles of different GBMs with specific 
physicochemical properties. As discussed in the main text, the density of carbon 
radicals represents a further parameter to be considered. An improved understanding 
of the impact of fundamental material properties on the hazard potential of GBMs 
may aid in safe-by-design approaches to mitigate toxicity while at the same time 
preserving useful features.
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4Figure S1. Categorization of the GBMs used in recent studies in the Graphene 
Flagship according to their three fundamental properties: number of graphene layers, 
average lateral dimension, atomic carbon/oxygen ratio. Based on: Wick et al. 2014. 
GO, graphene oxide; FLG, few-layer graphene; GNP, graphene nanoplatelets. GO 
materials are circled. Refer to Table S1 for details on the publications used to 
generate this figure.
5Table S1. Data and parameters used to generate Figure S1.
Material (commercial 
source)
Size/lateral 
dimensions [nm]
Number of 
layers/thickness C:O ratio Ref.
GO
GO (Antolin)
GO (NanoInnova)
>1000
>1000
400-1000
1-2
1-2
20 
1.9
2.17 
1.92
R. Kurapati et al., Small 2015, 
11, 3985
GO 0H*
GO 2H
GO 26H
1320
270
130
1 
1.9
1.9
1.9
J. Russier et al., Nanoscale 
2013, 5, 11234
Small GO 50-300 2-3 2.27 M. Orecchioni et al., Nature Comm. 2017, 8, 1109
Large GO
Small GO
1000-10000
50-500
1-2
1-2
2.2
2.3
M. Orecchioni et al., Adv. 
Healthc. Mater. 2016, 5, 276
GO (CheapTubes) 1000-40000 1-4 1.7±0.1
M. Kucki et al., Nanoscale 2016, 
8, 8749; M. Kucki et al., J. 
Nanobiotechnol. 2017, 15:46; B. 
Drasler et al., Carbon 2018 [in 
press]; M. Kucki et al., 2D 
Materials 2018, 5, 035014
GO 360±188 1 1.9
M. Kucki et al., Nanoscale 2016, 
8, 8749; M. Kucki et al., 2D 
Materials 2018, 5, 035014
GO 150±44 1 1.9
M. Kucki et al., Nanoscale 2016, 
8, 8749; M. Kucki et al., J. 
Nanobiotechnol. 2017, 15:46; M. 
Kucki et al., 2D Materials 2018, 
5, 035014
GO (Antolin) 20-1400 1-4 2.61
M. Kucki et al., Nanoscale 2016, 
8, 8749; D. Guarnieri et al., 
Small 2018, 1800227; M. Kucki 
et al., 2D Materials 2018, 5, 
035014 
GNP (CheapTubes) 1000-10000 >10 (20) 24±2.5
M. Kucki et al., Nanoscale 2016, 
8, 8749; M. Kucki et al., J. 
Nanobiotechnol. 2017, 15:46; B. 
Drasler et al., Carbon 2018 [in 
press]
GO-A (Nacional Grafite Ltd., Brasil)
GO-B (Nacional Grafite Ltd., Brasil)
GO-C (Antolin)
GO-D (Graphenea)
FLG
10000-15000
15000-20000
  85±50
800-7000
630±390
1-2
1-2 
1-4
1-2
≤4
2.4
2.2
0.9 
2.2
9.4
S.P. Mukherjee et al., PLoS 
ONE 2016, 11, 0166816; D. 
Guarnieri et al., Small 2018, 
1800227; M. Kucki et al., 2D 
Materials 2018, 5, 035014 
* 0H, 2H, and 26H correspond to the time of sonication of the GO solutions.
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Figure S2. Macrophage studies. Categorization of the different GBMs tested in in 
vitro publications using macrophages according to their three fundamental properties, 
i.e., number of graphene layers, average lateral dimension, and atomic 
carbon/oxygen ratio. Note that some properties of GO are not well reported in the 
literature (e.g., one of the three parameters is sometimes missing), and have been 
extrapolated considering that Hummers' method was the most used in the synthesis 
of GO; as the C/O ratio does not vary much from one sample to another, an average 
value of 1.5 was used. The color codes of the balls highlight the inertness (cyan) and 
cytotoxicity (red) of the different materials (for further details, refer to the 
accompanying Table S2).
7Table S2. Data and parameters used to generate Figure S2.
Material (commercial 
source)
Size/lateral 
dimensions [nm]
Number of 
layers/thicknes
s
C:O ratio Ref.
FLG 625 3-4 13.3 J. Russier et al., Angew. Chem. Int. Ed. 2017, 5, 11234
Oxidized graphene (oxG) 50-500 (AFM)250-1750 (TEM) 8.5 nm 14.1
G. F. Erf et al., J. Appl. Toxicol. 
2017, 37, 1317
GO 0H*
GO 2H
GO 26H
1320
270
130
1
1
1
1.9
1.9
1.9
J. Russier et al., Nanoscale 2013, 5, 
11234
GO 3000 1 0.78 X. Wu et al., Colloids Surf. B Biointerfaces, 2017, 157, 1
nGO 200 1 2.25 N. Luo et al., Nat. Commun. 2017, 8, 14537
GO 2000 1 2.25 L. A. Visani de Luna et al., J. Nanobiotechnol. 2016, 14:12
Small GO
Intermediate GO
Large GO
50-350
350-750
750-1300
1
1
1
2.25 J. Ma et al., ACS Nano 2015, 9 10498
Nanographite (nGr)
Oxidized nanographite (oxGr)
4500
4500
60 
80 
11.5
6.14
A. Figarol et al., Toxicol. In Vitro 
2015, 30, 476
GO
Reduced GO
1100
3500
1 
few layers
2.8
3.1
S. A. Sydlik et al., ACS Nano 2015, 
9, 3866
nGO 150 1 2.25 N. Luo et al., ACS Appl. Mater. Interfaces 2015, 7, 5239
GO 450 1 2.25 Y. Li et al., Small 2014, 10, 1544
Graphene microsheets (Gµ) 4250 10.5 19 Y. Li et al., PNAS 2013, 110, 12295
GO 475 1 2.25 B. Wan et al., Toxicol. Lett. 2013 22, 118
GO 1500 1 2.25 G. Qu et al., ACS Nano 2013, 7, 5732
Large GO
Small GO
2400
350
1
1 2.25
G. Y. Chen et al., Biomaterials 2012, 
33, 6559
Large GO
Small GO
2000
350
4 
4 2.25
H. Yue et al., Biomaterials 2012, 33, 
4013
Pristine graphene (G)
Oxidized graphene (oxG)
160
128
2
2
54.87
1.78
A. Sasidharan et al., Small 2012, 8, 
1251
Pristine graphene in 1% pluronic 
F108 750 4 19
Y. Li et al., Biomaterials 2012, 33 
402
Large GO
Small GO
1000-10000
50-500
1-2
1-2
2.2
2.3
M. Orecchioni et al., Adv. Healthc. 
Mater. 2016, 5, 276
Small GO 50-300 2-3 2.27 M. Orecchioni et al., Nat. Commun. 2017, 8, 1109
Large GO
Small GO
10000-40000
50-300
1-2
1-2
2.2
2.3
S. Mukherjee et al., Chem 2018, 4, 
334;  S. Mukherjee et al., Adv. 
Healthc. Mater. 2018, 7, 1700815
GO-A (Nacional Grafite Ltd., Brasil)
GO-B (Nacional Grafite Ltd., Brasil)
GO-C (Antolin)
GO-D (Graphenea)
FLG
10000-15000
15000-20000
  85±50
800-7000
630±390
1-2
1-2
1-4
1-2
≤4
2.4
2.2
0.9 
2.2
9.4
S.P. Mukherjee et al., PLoS ONE 
2016, 11, 0166816
* 0H, 2H, and 26H correspond to the time of sonication of the GO solutions.
** For oxidized graphene, GO or rGO, The thickness of about 1 nm corresponds to 1 layer.
*** C/O values not present in the publications were kindly provided by the authors.
8Figure S3. Biodegradation. Categorization of the GBMs tested in studies on 
degradation reported in the literature according to their three fundamental properties, 
i.e., number of graphene layers, average lateral dimension, and atomic 
carbon/oxygen ratio. For detailed discussions of all of these studies, refer to main 
text. The colour codes of the balls correspond to degradable (red), non-degradable 
(green) and partially degradable (cyan) materials. The oval circle groups GO 
materials of different lateral sizes. Refer to Table S3 for details on the publications 
used to generate this figure.
9Table S3. Data and parameters used to generate Figure S3.
Material 
(commercial 
source)
Size/lateral 
dimensions [nm]
Number of 
layers/ 
thickness**
C/O 
ratio***
Oxidation 
system Ref.
GO
Reduced GO
500-1500
500-1500
0.61 nm
1.73 nm
2.25
5
HRP G. P. Kotchey et al., ACS Nano. 2011, 5, 2098
GONRs
Reduced GONRs
2000
2000
Multi-layer (20)
Multi-layer (20)
5.66
19
LiP / VA G. Lalwani et al., J. Mater. Chem. B 2014, 2, 6354
GO
Reduced GO
476
476
1-2 
1-2
1.93
12
Naphthalene-
degrading bacteria
L. Liu et al., Nanoscale 
2015, 7, 13619
GO 589±700 0.972 nm 1 P.F. reaction
H. Bai et al., J. Phys. 
Chem. C 2014, 118, 
10519
GO 400-500 1 nm 2.25 HRP Y. Li et al., Small 2014, 10, 1544
GO
Reduced GO
Graphene (G)
Not given* Not given
2.09
6.79
10.26
HRP C. Zhang et al., Carbon 2015, 94, 531
Oxidized graphene 128 2 1.77 Macrophages
G. M. Girish et al., Adv. 
Healthc. Mater. 2013, 2, 
1489
GO
GO (Antolin)
GO (NanoInnova)
>1000
>1000
400-1000
1-2
1-2
20
1.9
2.17
1.92
MPO R. Kurapati et al., Small 2015, 11, 3985
GO 800-3000 2 2.17 HRP R. Kurapati et al., 2D Mater. 2018, 5, 015020
GO 900±500 2.3±1.1 nm 2.4 NaClO L. Newman et al., NPJ 2D Mater. Appl. 2017, 1, 39 
Large GO
Small GO
10000±8000
100±50
1-2 nm
1-2 nm
2.1
2.1
MPO/Primary
human neutrophils
S. P. Mukherjee et al., 
Nanoscale 2018, 10, 1180
* This example cannot be inserted in the 3D plot because of the missing data on size and thickness.
** For oxidized graphene, GO or rGO, The thickness of about 1 nm corresponds to 1 layer.
*** C/O values not present in the publications were kindly provided by the authors.
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Figure S4. Pulmonary studies. Categorization of the GBMs tested in studies in vitro 
and in vivo on pulmonary impact reported in the literature according to their three 
fundamental properties, i.e., number of graphene layers, average lateral dimension, 
and atomic carbon/oxygen ratio. The colour codes of the balls correspond to 
materials that are inflammogenic, provoke lung injuries and granulomas (red), and 
materials that do not show sign of inflammation or cellular responses (cyan). For 
detailed discussions of all of these studies, refer to main text. See Table S4 for 
details on these publications.
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Table S4. Data and parameters used to generate Figure S4.
Material Size/lateral dimensions [nm]
Number of 
layers/thickness C:O ratio Ref.
GO 300 2 2.5 A. Boucetta et al., Adv. Healthcar. Mater. 2013, 2, 433
FLG 325 5 14.8 L. Mao et al., Part. Fibre Toxicol. 2016, 13:7
GNP 550 10 9.8 J. H. Shin et al., Nanotoxicology 2015, 9, 1023
GNP 1000 25 25 J. K. Kim et al., Nanotoxicology 2016, 10, 891
GO 405 2 2.5 B. Li et al., NPG Asia Mater. 2013, 5, e44
GO 158 1.25 nm 2.5 M. C. Duch et al., Nano Lett.  2011, 11, 5201
GO 2500 2 1.4
rGO 1500 2 8.5
S. Bengtson et al., PLoS One 2017, 12, 
e01783552017
GO 2500 2 1.4
rGO 1500 2 8.5
rGO 1500 2 7.6
S. Bengtson et al., Environ. Mol. Mutagen. 
2016, 57, 469
GO 2510 1 2.5 M. R. Shurin et al., ACS Nano 2012, 8, 5585
GO 225 1 2.5
GO 550 1 2.5
GO 1050 1 2.5
J. Ma et al., ACS Nano 2015, 10, 10498
GO 1676 1 2.5
GO 179 1 2.5
X. Wang et al., ACS Nano 2015, 9, 3032
GO 170 1 2.2
GO 1723 1 2.2
S. Vranic et al.,ACS Nano 2018, 12, 1373
GO
hydrated GO (hGO)
rGO
334
330
549
1
3
3 
1.72 
2.60
5.06
R. Li et al., ACS Nano 2018, 12, 1390
GO
GNP
1000-10000
1000-2000
1
5-10
1.7
24 B. Drasler et al., Carbon 2018 [in press]
12
Figure S5. Gastrointestinal studies. Categorization of the GBMs tested in studies in 
vitro using intestinal cells reported in the literature according to their three 
fundamental properties, i.e., number of graphene layers, average lateral dimension, 
and atomic carbon/oxygen ratio. The cyan color of the balls refers to the relative 
inertness of all materials represented in the 3D plot, which trigger a cellular response 
only at the highest doses. For detailed discussions of these studies, refer to main 
text, and Table S5.
Table S5. Data and parameters used to generate Figure S5.
Material 
(commercial 
source)
Size/lateral 
dimensions [nm]
Number of 
layers/thickness
C:O 
ratio Ref.
GO (CheapTubes) 1000-40000 1-4 1.7±0.1 M. Kucki et al., Nanoscale 2016, 8, 8749;  M. Kucki et al., J. Nanobiotechol. 2017, 15:46
GO 360±188 1 1.9 M. Kucki et al., Nanoscale 2016, 8, 8749
GO 150±44 1 1.9 M. Kucki et al., Nanoscale 2016, 8, 8749;  M. Kucki et al., J. Nanobiotechol. 2017, 15:46
GO (Antolin) 20-1400 1-4 2.61 M. Kucki et al., Nanoscale 2016, 8, 8749; D. Guarnieri et al., Small 2018, 1800227
GNP (CheapTubes) 1000-10000 >10 layers (20) 24±2.5 M. Kucki et al., Nanoscale 2016, 8, 8749;  M. Kucki et al., J. Nanobiotechol. 2017, 15:46
FLG 630±390 4 9.4 D. Guarnieri et al., Small 2018, 1800227
